Osteoporosis: Epidemiology Forecast to 2027

Osteoporosis: Epidemiology Forecast to 2027

  • April 2018 •
  • 41 pages •
  • Report ID: 5392244 •
  • Format: PDF
Osteoporosis: Epidemiology Forecast to 2027

Summary
Osteoporosis is a disease in which the density and quality of bone are reduced over time.In a normal process known as remodeling, some of a person’s bone cells dissolve (resorption) and new bone cells grow back (formation).

The bones become so weak and brittle that a fall or even mild stresses such as bending over or coughing can cause a fracture.

To forecast the total prevalent cases and diagnosed prevalent cases of osteoporosis and osteopenia in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies that provided these epidemiological data in the 7MM.GlobalData epidemiologists obtained data for the total prevalent cases of osteoporosis secondary to glucocorticoid use from primary market research.

In addition, the forecast is supported by robust, country-specific data that were obtained from various authentic sources, such as research articles published in peer-reviewed journals.

In the 7MM, the total prevalent cases of osteoporosis will increase from 45,617,583 cases in 2017 to 52,482,628 cases in 2027, at an Annual Growth Rate (AGR) of 1.50%. In the 7MM, the diagnosed prevalent cases of osteoporosis will increase from 21,637,066 cases in 2017 to 24,553,120 cases in 2027, at an AGR of 1.35%. GlobalData forecasts that all markets will see an increase in the total prevalent cases and diagnosed prevalent cases of osteoporosis during the forecast period.

Scope
- The Osteoporosis Epidemiology Report provides an overview of the risk factors and global trends of osteoporosis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- This report ncludes a 10-year epidemiological forecast for the total and diagnosed prevalent cases of osteoporosis, and total and diagnosed prevalent cases of primary osteoporosis, segmented by sex and age in these markets. In addition, this report provides a 10-year epidemiological forecast for the total and diagnosed prevalent cases of secondary osteoporosis, total and diagnosed prevalent cases of osteopenia, segmented by sex. The report also includes the total and diagnosed prevalent cases of type 1 (postmenopausal) osteoporosis, and the total and diagnosed prevalent cases of type 2 (age-associated/ senile) osteoporosis, and total and diagnosed prevalent cases of osteoporosis secondary to glucocorticoid use.
- The osteoporosis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy
The Osteoporosis Epidemiology report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global osteoporosis market.
- Quantify patient populations in the global osteoporosis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for osteoporosis therapeutics in each of the markets covered.
- Understand magnitude of osteoporosis types in each market.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.